Dual GIP/GLP-1 receptor agonist showing superior weight loss compared to GLP-1 agonists alone. Brand names include Mounjaro and Zepbound.
Key Data
Mechanism of Action
Activates both GIP and GLP-1 receptors for enhanced metabolic effects and greater weight loss.
Reported Benefits
All information is presented for Research Use Only (RUO). Not medical advice.